GC-targeted C8-linked pyrrolobenzodiazepine–biaryl conjugates (Spirogen/King's College London/University of Southampton)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGC-targeted C8-linked pyrrolobenzodiazepine–biaryl conjugates (Spirogen/King's College London/University of Southampton)
Drug Alias NameKMR-2839
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalators
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesADC Products (UK) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A